LRP-mediated clearance of Aβ is inhibited by KPI-containing isoforms of APP

Current Alzheimer Research

Volumn 2, Issue 2, 2005, Pages 269-273

  Moir, Robert D ^a   Tanzi, Rudolph E ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Genetics and Aging Research Unit   (United States)

Author keywords

2 macroglobulin ( 2M); A ; Alzheimer's disease; Amyloid protein precursor (APP); Apolipoprotein E (APOE); Clearance; Low density lipoprotein receptor related protein (LRP)

Indexed keywords

ALPHA 2 MACROGLOBULIN; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; APROTININ; CHAPERONE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; PROTEINASE INHIBITOR;

ALZHEIMER DISEASE; BINDING SITE; BLOOD BRAIN BARRIER; BRAIN; BRAIN BLOOD VESSEL; CATABOLISM; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; NEUROPIL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING;

AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; APROTININ; CERCOPITHECUS AETHIOPS; COS CELLS; HUMANS; LDL-RECEPTOR RELATED PROTEINS; PROTEIN BINDING; PROTEIN ISOFORMS;

EID: 20844433715     PISSN: 15672050     EISSN: None     Source Type: Journal    
DOI: 10.2174/1567205053585918     Document Type: Conference Paper

References (17)

1. Glenner GG and Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120: 885-890 (1984).
2. Tanzi RE, McClatchey AI, Lamperti ED, Villa-Komaroff L, Gusella JF and Neve RL. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature 331: 528-530 (1988).
3. Kitaguchi N, Takahashi Y, Tokushima Y, Shiojiri S and Ho H. Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature 331: 530-532 (1988).
4. Sisodia SS, Koo EH, Beyreuther K, Unterbeck A and Price DL. Evidence that β-amyloid protein in Alzheimer's disease is not derived by normal processing. Science 248: 492-495 (1990).
5. Esch FS, Keim PS, Beattie EC, Blacker RW, Culwell AR, Oltersdorf T, et al. Cleavage of amyloid β peptide during constitutive processing of its precursor. Science 248: 1122-1124 (1990).
6. Moir RD, Lynch T, Bush AI, Whyte S, Henry A, Portbury S, et al. Relative increase in Alzheimer's disease of soluble forms of cerebral Aβ amyloid protein precursor containing the Kunitz protease inhibitory domain. J Biol Chem 273: 5013-9 (1998).
7. Kitaguchi N, Tokushima Y, Oishi K, Takahashi Y, Shiojiri S, Nakamura S, et al. Determination of amyloid β protein precursors harboring active form of proteinase inhibitor domains in cerebrospinal fluid of Alzheimer's disease patients by trypsin-antibody sandwich ELISA. Biochem Biophys Res Commun 166: 1453-1459 (1990).
8. Tanzi RE, Bird ED, Latt SA and Neve RL. The amyloid β protein gene is not duplicated in brains from patients with Alzheimer's disease. Science 238: 666-669 (1987).
9. Johnston JA, Froelich S, Lannfelt L and Cowburn RF. Quantification of presenilin-1 mRNA in Alzheimer's disease brains. FEBS Lett 394: 279-84 (1996).
10. Zhan SS, Sandbrink R, Beyreuther K and Schmitt HP. APP with kunitz type protease inhibitor domain (KPI) correlates with neuritic plaque density but not with cortical synaptophysin immunoreactivity in Alzheimers Disease and non-demented aged subjects: a multifactorial analysis. Clin Neuropathol 14: 142-149 (1995).
11. Kounnas MZ, Moir RD, Rebeck GW, Bush AI, Argraves WS, Tanzi RE, et al. LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation. Cell 82: 331-340 (1995).
12. Ulery PG, Beers J, Mikhailenko I, Tanzi RE, Rebeck GW, Hyman BT, et al. Modulation of beta-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP). Evidence that LRP contributes to the pathogenesis of Alzheimer's disease. J Biol Chem 275: 7410-5 (2000).
13. Zlokovic BV. Clearing amyloid through the blood-brain barrier. J Neurochem 89: 807-11 (2004).
14. Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, et al. Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest 106: 1489-99 (2000).
15. Van Uden E, Mallory M, Veinbergs I, Alford M, Rockenstein E and Masliah E. Increased extracellular amyloid deposition and neurodegeneration in human amyloid precursor protein transgenic mice deficient in receptor-associated protein. J Neurosci 22: 9298-304 (2002).
16. Moir RD, Martins RN, Bush AI, Small DH, Milward EA, Rumble BA, et al. Human brain βA4 amyloid protein precursor of Alzheimer's disease: purification and partial characterization. J Neurochem 59: 1490-1498 (1992).
17. Willnow TE and Herz J. Genetic deficiency in low density lipoprotein receptor-related protein confers cellular resistance to Pseudomonas exotoxin A. Evidence that this protein is required for uptake and degradation of multiple ligands. J Cell Sci 107: 719-26 (1994).